Volume 26; Issue 5

Expert Opinion on Investigational Drugs

Volume 26; Issue 5

1

Heat shock protein antagonists in early stage clinical trials for NSCLC

Hendriks, Lizza E.L., Dingemans, Anne-Marie C.

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 1.00 MB

english, 2017

2

A randomized, double-blind, single-dose, two-arm, parallel study comparing pharmacokinetics, immunogenicity and tolerability of branded adalimumab and its biosimilar LBAL in healthy male volunteers

Park, Kyoung Ryun, Chung, Hyewon, Yang, Sung Mo, Lee, SeungHwan, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin, Yu, Kyung-Sang

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 952 KB

english, 2017

3

PPAR-α agonists are still on the rise: an update on clinical and experimental findings

Ferri, Nicola, Corsini, Alberto, Sirtori, Cesare, Ruscica, Massimiliano

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 674 KB

english, 2017

4

Preclinical to phase II amyloid beta (A β ) peptide modulators under investigation for Alzheimer’s disease

Parsons, Chris G., Rammes, Gerhard

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 1.04 MB

english, 2017

5

Pharmacotherapeutic agents in the treatment of methamphetamine dependence

Morley, Kirsten C., Cornish, Jennifer L., Faingold, Alon, Wood, Katie, Haber, Paul S.

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 847 KB

english, 2017

6

Investigational therapies for hypercholesterolemia

Tomkin, Gerald H., Owens, Daphne

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 1.27 MB

english, 2017

7

Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia

Vangapandu, Hima V., Jain, Nitin, Gandhi, Varsha

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 837 KB

english, 2017

8

Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug

Gervasini, Guillermo, Robles, Nicolas Roberto

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 1.27 MB

english, 2017

9

Perspectives of HER2-targeting in gastric and esophageal cancer

Gerson, James N, Skariah, Sam, Denlinger, Crystal S., Astsaturov, Igor

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 683 KB

english, 2017

10

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

Rijavec, Erika, Genova, Carlo, Barletta, Giulia, Biello, Federica, Rossi, Giovanni, Tagliamento, Marco, Dal Bello, Maria Giovanna, Coco, Simona, Vanni, Irene, Boccardo, Simona, Alama, Angela, Grossi,

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 803 KB

english, 2017

11

Therapeutic targeting of isocitrate dehydrogenase mutant AML

Boddu, Prajwal, Borthakur, Gautam

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 1008 KB

english, 2017

12

Lenalidomide in the treatment of chronic lymphocytic leukemia

Itchaki, Gilad, Brown, Jennifer R.

Journal:

Expert Opinion on Investigational Drugs

Year:

2017

Language:

english

File:

PDF, 1.58 MB

english, 2017